EUVIMEDScopri EUVIMED
Crossref

Levoglucosenone‐Derived Isothiocyanates as Antifungal Compounds: Merging Sustainability and Medicinal Chemistry

Florencia Cámpora, Beatriz E Pava-Gómez, Darián Vazquez, Maximiliano Sortino, Laura Svetaz, María I Mangione iD, Alejandra G Suárez, Ariel M Sarotti iD, Camilla Matassini iD, Francesca Cardona iD, Rolando A Spanevello

ChemMedChem · 2026-06-26 · 21 (12)

DOI: 10.1002/cmdc.70357 ↗

At a glance

Journal article in ChemMedChem, published online on 2026-06-26. Written by Florencia Cámpora and 10 co-authors. Institution: Departamento de Química Orgánica, Instituto de Química Rosario, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario - C…. Major MEDLINE topics: Antifungal Agents, Isothiocyanates, Glucose. Cited 2 times so far (Crossref); 58 references. Funded by: Agencia Nacional de Promoción Científica y Tecnológica, Consejo Nacional de Investigaciones Científicas y Técnicas, Universidad Nacional de Rosario.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

The increasing generation of agricultural biomass waste constitutes a significant environmental and climatic concern, while simultaneously offering opportunities for its valorization into high‐value products. Levoglucosenone, a cellulose‐derived platform molecule, provides access to structurally distinctive bicyclic acetals with considerable relevance in medicinal chemistry. In this study, we investigated the synthesis and antifungal properties of novel isothiocyanate derivatives incorporating the 6,8‐dioxabicyclo[3.2.1]octene scaffold. A synthetic approach based on the introduction of a thiocyanate group, followed by a [3,3]‐sigmatropic rearrangement, enabled the efficient preparation of two isothiocyanate derivatives. Optimization of reaction conditions led to improved yields, while comprehensive structural characterization confirmed the regio‐ and stereoselective nature of the transformations. Biological evaluation demonstrated broad‐spectrum antifungal activity against clinically relevant pathogens, including Candida , Cryptococcus , Aspergillus , and dermatophytes, with compound 7 consistently exhibiting superior potency. Both compounds displayed fungicidal activity and effectively inhibited key virulence factors at sub‐inhibitory concentrations. In particular, they impaired Candida albicans morphogenesis and suppressed urease activity and melanin production in Cryptococcus species, without affecting capsule formation. These findings underscore the potential of levoglucosenone‐derived isothiocyanates as promising scaffolds for antifungal drug development, combining potent growth inhibition with the ability to disrupt critical pathogenic mechanisms.

Subjects

MeSH terms (MEDLINE)

Antifungal AgentsIsothiocyanatesGlucoseMicrobial Sensitivity TestsStructure-Activity RelationshipAspergillusMolecular StructureCandidaChemistry, PharmaceuticalDose-Response Relationship, DrugArthrodermataceaeBridged Bicyclo Compounds, Heterocyclic

Author keywords

antifungal activitybiomass wasteisothiocyanate derivateslevoglucosenonesigmatropic rearrangement

Substances

Antifungal AgentsIsothiocyanatesGlucose1,6-anhydro-3,4-dideoxyhex-3-enopyran-2-uloseBridged Bicyclo Compounds, Heterocyclic

Authors and institutions

  • Departamento de Química Orgánica, Instituto de Química Rosario, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario - CONICET, Rosario, Argentina.
  • Área Farmacognosia, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario - CONICET, Rosario, Argentina.
  • Dipartimento di Chimica 'Ugo Schiff' (DICUS), Università degli Studi di Firenze, Sesto Fiorentino, Florence, Italy.

ORCID profiles: María I Mangione, Ariel M Sarotti, Camilla Matassini, Francesca Cardona

Funding

  • Agencia Nacional de Promoción Científica y Tecnológica
  • Consejo Nacional de Investigaciones Científicas y Técnicas
  • Universidad Nacional de Rosario

Cite

APA

Cámpora, F., Pava-Gómez, B. E., Vazquez, D., Sortino, M., Svetaz, L., Mangione, M. I., Suárez, A. G., Sarotti, A. M., Matassini, C., Cardona, F., & Spanevello, R. A. (2026). Levoglucosenone‐Derived Isothiocyanates as Antifungal Compounds: Merging Sustainability and Medicinal Chemistry. ChemMedChem, 21(12). https://doi.org/10.1002/cmdc.70357

Vancouver

Cámpora F, Pava-Gómez BE, Vazquez D, Sortino M, Svetaz L, Mangione MI, et al. Levoglucosenone‐Derived Isothiocyanates as Antifungal Compounds: Merging Sustainability and Medicinal Chemistry. ChemMedChem. 2026;21(12). doi:10.1002/cmdc.70357

BibTeX
@article{Cmpora2026,
  author = {Cámpora, Florencia and Pava-Gómez, Beatriz E and Vazquez, Darián and Sortino, Maximiliano and Svetaz, Laura and Mangione, María I and Suárez, Alejandra G and Sarotti, Ariel M and Matassini, Camilla and Cardona, Francesca and Spanevello, Rolando A},
  title = {Levoglucosenone‐Derived Isothiocyanates as Antifungal Compounds: Merging Sustainability and Medicinal Chemistry},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {12},
  doi = {10.1002/cmdc.70357}
}
Start for free →